David A. Siegel Ocular Therapeutix, Inc Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 37,300 shares of OCUL stock, worth $402,094. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,300Holding current value
$402,094% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding OCUL
# of Institutions
157Shares Held
139MCall Options Held
86.4KPut Options Held
263K-
Summer Road LLC West Palm Beach, FL14.9MShares$160 Million98.56% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$138 Million9.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$137 Million2.86% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.61MShares$92.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $830M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...